Literature DB >> 2410496

T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.

P Brottier, L Boumsell, C Gelin, A Bernard.   

Abstract

Binding monoclonal antibodies (MAb) both to D66 and 9.6/T11(1) epitopes on the CD2 [T,gp50]-defined molecule produces a high level of T cell mitosis. This was observed with a battery of MAb of different isotypes. In contrast, none of the anti-D66 or anti-9.6/T11(1)Ab could trigger T cell proliferation in combination with anti-T11(3). Moreover, all anti-D66-9.6/T11(1) pairs of MAb tested required monocytes to activate T cells which were recruited through their Fc receptors. Variations among normal individuals were observed in the level of response to anti-D66-9.6/T11(1) pairs of Ab, 75% of a population of French Caucasians giving a high response. The level of response of a given individual was determined by his accessory cells. However, the level of response of an individual appeared to be minimally influenced by the isotype of a peculiar anti-D66 or anti-9.6/T11(1) Ab. The addition of exogeneous IL 2 could overcome the removal of accessory cells or the modulation of CD3 molecules. In contrast, IL 2 receptor appearance was not overcome by removal of monocytes. Thus, T cell activation via CD2 seems to be produced by "touching" several definite regions of this molecule which trigger a cascade of events similar to those produced by mitogenic lectins. One can assume that the appropriate conformational changes of the CD2 molecule induced by anti-D66-9.6/T11(1) pairs of Ab are solely produced when they are presented by accessory cells. This leaves open the question of whether accessory cells would also play a more active role.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410496

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B.

Authors:  C García-Monzón; R Moreno-Otero; L García-Buey; M López-Botet; M O De Landázuri; F Sánchez-Madrid
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Pharmacokinetics, biologic activity, and tolerability of alefacept by intravenous and intramuscular administration.

Authors:  Ashay K Vaishnaw; Christopher N TenHoor
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-12       Impact factor: 2.745

3.  Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes.

Authors:  C H June; J A Ledbetter; P S Rabinovitch; P J Martin; P G Beatty; J A Hansen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

4.  CD2 and other surface molecules in the regulation of non-MHC-restricted cytolytic function.

Authors:  W C Chan; G Ye; S Link; A C Mawle; J K Nicholson
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

5.  Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes.

Authors:  J A Ledbetter; C H June; L S Grosmaire; P S Rabinovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.

Authors:  M D Dodon; A Bernard; L Gazzolo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation.

Authors:  B E Bierer; A Peterson; J Barbosa; B Seed; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.

Authors:  S Huet; L Boumsell; B Raynal; L Degos; J Dausset; A Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses.

Authors:  E Early; D J Reen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

10.  Intracellular mediators regulate CD2 lateral diffusion and cytoplasmic Ca2+ mobilization upon CD2-mediated T cell activation.

Authors:  S J Liu; W C Hahn; B E Bierer; D E Golan
Journal:  Biophys J       Date:  1995-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.